Entropy Technologies LP bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 13,495 shares of the company's stock, valued at approximately $1,596,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Eastern Bank acquired a new stake in Cardinal Health in the 3rd quarter valued at about $25,000. Frazier Financial Advisors LLC raised its position in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after acquiring an additional 104 shares in the last quarter. Hara Capital LLC acquired a new stake in shares of Cardinal Health during the 3rd quarter worth about $31,000. AM Squared Ltd acquired a new stake in shares of Cardinal Health during the 3rd quarter worth about $33,000. Finally, Carolina Wealth Advisors LLC acquired a new stake in shares of Cardinal Health during the 3rd quarter worth about $47,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms recently issued reports on CAH. Barclays raised their price target on Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. UBS Group lifted their target price on Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a research note on Monday, November 4th. Citigroup lifted their target price on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Finally, Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $136.87.
Read Our Latest Stock Report on CAH
Cardinal Health Stock Up 0.1 %
Shares of Cardinal Health stock traded up $0.10 during trading on Thursday, reaching $127.16. The company's stock had a trading volume of 2,390,521 shares, compared to its average volume of 2,391,894. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84. The company has a market capitalization of $30.72 billion, a P/E ratio of 23.72, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The business has a 50 day moving average price of $122.78 and a 200-day moving average price of $115.99.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.59%. Cardinal Health's dividend payout ratio is presently 37.69%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
